FDA Inspection 1204459 — South Florida Institute for Reproductive Medicine
The FDA completed an inspection of South Florida Institute for Reproductive Medicine on April 19, 2023 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 19, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Naples, FL (United States)